factor VIII - CISMeF

Preferred Label : factor VIII;

MeSH definition : Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.; Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.;

MeSH synonym : coagulation factor viii; blood coagulation factor viii; thromboplastinogen; Factor 8; Factor Eight;

CISMeF synonym : humate p; humatep; factor viii, coagulation; viii, coagulation factor; factor viii heavy chain; factor viii-heavy chain; speywood brand of porcine factor VIII preparation;

DeCS synonym : Factor 8 C;

MeSH hyponym : hyate-c; Hyatt-C; Hyatt C; HyattC; Hyate C; HyateC;

Related MeSH term : factor VIIIC; factor VIII procoagulant activity; factor VIII coagulant antigen; Factor 8 C; F VIII-C; F VIII C; Factor VIII Clotting Antigen;

MeSH CAS label : blood-coagulation factor VIII, complex;

Registry Number MeSH : 9001-27-8;

Wikipedia link : https://en.wikipedia.org/wiki/Factor VIII;

Codes EINECS : 232-593-9;

Is substance : O;

Details

Origin ID

D005169;

UMLS CUI

C0015506;

ATC code(s)
- coagulation factor VIII [ATC Code]
- von willebrand factor and coagulation factor VIII in combination [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- blood-coagulation factor viii [Substance BNPC]
Currated CISMeF NLP mapping
- Antihaemophilic factor [MedDRA LLT]
- Antihemophilic Factor, Human Recombinant [NCIt concept]
- Antihemophilic factor [MedDRA LLT]
- Coagulation Factor VIII [NCIt concept]
- Coagulation factor VIII [LOINC component]
- Coagulation factor VIII (substance) [SNOMED CT concept]
- coagulation factor viii [SNOMED Notion]
Indexing information
- hemocytin protein, bombyx mori [MeSH Supplementary Concept]
- vueffe [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Coagulation factor VIII [ICD-11 Extension code]
Pharmacological action(s)
- coagulants [MeSH Descriptor]
Record concept(s)
- Hyatt-C [MeSH concept]
- factor VIII [MeSH concept]
- factor VIII coagulant antigen [MeSH concept]
- factor VIII procoagulant activity [MeSH concept]
- factor VIIIC [MeSH concept]
Related MeSH Supplementary Concept(s)
- B-domain-deleted factor VIII [MeSH Supplementary Concept]
- BAX 855 [MeSH Supplementary Concept]
- BAY 14-2222 [MeSH Supplementary Concept]
- BAY 94-9027 [MeSH Supplementary Concept]
- F8 protein, human [MeSH Supplementary Concept]
- N8-GP compound [MeSH Supplementary Concept]
- Valoctocogene Roxaparvovec [MeSH Supplementary Concept]
- asialo-Factor VIII [MeSH Supplementary Concept]
- cryobulin [MeSH Supplementary Concept]
- cryoprecipitate coagulum [MeSH Supplementary Concept]
- factor VIII (des-797-1562) [MeSH Supplementary Concept]
- factor VIII delta II [MeSH Supplementary Concept]
- factor VIII ise [MeSH Supplementary Concept]
- factor VIII leiden [MeSH Supplementary Concept]
- factor VIII, von Willebrand factor drug combination [MeSH Supplementary Concept]
- factor VIII-Fc fusion protein [MeSH Supplementary Concept]
- factor VIII-von willebrand factor concentrate 8Y [MeSH Supplementary Concept]
- immunate solvent detergent, human [MeSH Supplementary Concept]
- kryobulin TIM3 [MeSH Supplementary Concept]
- malmo protocol [MeSH Supplementary Concept]
- optivate [MeSH Supplementary Concept]
- recombinant FVIII, sugar formulated [MeSH Supplementary Concept]
- recombinant factor VIII N8 [MeSH Supplementary Concept]
- recombinant factor VIII SQ [MeSH Supplementary Concept]
Related MeSH term(s)
- hemophilia A [MeSH Descriptor]
See also
- hemophilia A [MeSH Descriptor]
See also (suggested by CISMeF)
- coagulants [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Antihemophilic globulin [FMA entity]
- Coagulation factor VIII [LOINC component]
- Coagulation factor VIII (substance) [SNOMED CT concept]
- Factor VIII [LOINC component]
- Product containing coagulation factor VIII (medicinal product) [SNOMED CT concept]
- coagulation factor VIII [ATC Code]
- coagulation factor viii [SNOMED Notion]
Validated automatic mappings to BTNT
- coagulation factor VIII [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients